文献速递真菌感染新发突发、热带与寄生虫病

泰国猫源孢子丝菌复合体分离株体外抗真菌药敏分析(2023-2025)

In Vitro Antifungal Drug Susceptibility of Feline Sporothrix schenckii Complex Isolates, Thailand, 2023-2025.
PubMed 文献 · Emerg Infect Dis · 2026-01-01

对2023-2025年泰国实验室确诊的猫源孢子丝菌复合体感染分离株进行体外抗真菌药敏检测,共纳入1,178株。结果显示368株未出现敏感性降低,但687株对伊曲康唑敏感性降低,其中321株为单药降低、270株为共同降低、96株为多药降低。猫孢子丝菌病病例增加及伊曲康唑敏感性降低提示需持续监测和药敏试验。

要点

  • 1,178株猫源孢子丝菌复合体中,687株对伊曲康唑敏感性降低。
  • 伊曲康唑敏感性降低以单药为主(321株),另有270株共同降低、96株多药降低。
  • 对两性霉素B、泊沙康唑、伏立康唑、特比萘芬单药敏感性降低的菌株分别为60、41、9、4株。

核心结论

  • 猫孢子丝菌病病例增多且伊曲康唑敏感性降低增加,需持续监测和药敏试验以支持复杂病例管理。

研究设计与样本

  • 对2023-2025年泰国实验室确诊的猫源孢子丝菌复合体感染分离株进行体外抗真菌药敏检测,共1,178株。

主要发现

  • 368株分离株未显示敏感性降低。
  • 687株对伊曲康唑敏感性降低:321株单药降低、270株共同降低、96株多药降低。
  • 单药敏感性降低:两性霉素B 60株、泊沙康唑41株、伏立康唑9株、特比萘芬4株。

关键数值与推荐

  • 检测药物包括两性霉素B、伊曲康唑、泊沙康唑、伏立康唑、酮康唑、氟康唑和氟胞嘧啶。

临床怎么用

  • 对猫孢子丝菌病复杂病例应开展药敏试验,以指导治疗并监测伊曲康唑敏感性降低。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Feline sporotrichosis is a public health concern because it is a zoonotic illness and has a prolonged treatment time. We report laboratory-confirmed cases of feline Sporothrix schenckii complex infection submitted to a laboratory in Thailand during 2023-2025 and evaluate their in vitro antifungal drug susceptibility profiles for amphotericin B, itraconazole, posaconazole, voriconazole, ketoconazole, fluconazole, and flucytosine. A total of 1,178 S. schenckii complex isolates were identified. Overall, 368 isolates did not show reduced susceptibility. We observed single-drug reduced susceptibility to amphotericin B (60 isolates), posaconazole (41 isolates), voriconazole (9 isolates), and terbinafine (4 isolates). We observed a reduced susceptibility to itraconazole in 687 isolates: 321 single-drug, 270 co-reduced, and 96 multidrug-reduced isolates. An increasing number of feline sporotrichosis cases and escalating reduced susceptibility to itraconazole underscore the need for continued surveillance and susceptibility testing to support management in complex cases.

来源:Emerg Infect Dis,查看原文。版权归原作者所有。

引用

  1. Yurayart C, Yingchanakiat K, Thongbai A, et al. In Vitro Antifungal Drug Susceptibility of Feline Sporothrix schenckii Complex Isolates, Thailand, 2023-2025. Emerg Infect Dis. 2026. PMID: 42230305. doi:10.3201/eid3206.260135

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。